DCGI allows PNB Vesper Life Science to conduct phase-III clinical trials on PNB 001/GPP-BALACOVIN to… EP News Bureau Jun 24, 2021 PNB 001/GPP-BALACOVIN proving to be a major breakthrough in COVID-19 treatment
PNB Vesper completes Phase 2 of clinical trials of GPP-Baladol on COVID-19 patients EP News Bureau Feb 12, 2021 Clinical trial report to be submitted to Drug Controller General of India on February 22, 2021
PNB Vesper gets DCGI nod to test proprietary drug PNB 001 in COVID-19 patients EP News Bureau Sep 11, 2020 A study will be conducted on 40 moderately-ill COVID-19 patients at BMJ Medical College, Pune who are on oxygen support
PNB Vesper: Betting big on research Usha Sharma Sep 16, 2019 Kochi-based PNB Vesper’s semi-virtual web of researchers, universities, and CROs across continents has some promising leads in the…